These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 15005270)

  • 21. Biphasic changes in nitric oxide generation in hemodialyzed patients with end-stage renal disease treated with recombinant human erythropoietin.
    Kang ES; Wang YB; Cardenas R; Tevlin MT; Mishra S; Acchiardo SR
    Am J Med Sci; 2000 Mar; 319(3):149-57. PubMed ID: 10746825
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Soluble P-selectin during a single hemodialysis session in patients with chronic renal failure and erythropoietin treatment.
    Stasko J; Galajda P; Ivanková J; Hollý P; Rozborilová E; Kubisz P
    Clin Appl Thromb Hemost; 2007 Oct; 13(4):410-5. PubMed ID: 17911193
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Treatment of anemia with erythropoietin (rhuEPO) in patients with chronic kidney failure who are not yet in need of dialysis therapy].
    Wiecek A; Kokot F; Marcinkowski W; Rudka R; Klimek D
    Pol Arch Med Wewn; 1992 Nov; 88(5):310-23. PubMed ID: 1300551
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of erythropoietin on trace elements in patients with chronic renal failure undergoing hemodialysis.
    Hosokawa S; Yoshida O
    Nephron; 1993; 65(3):414-7. PubMed ID: 8289992
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Does long-term treatment of renal anaemia with recombinant erythropoietin influence oxidative stress in haemodialysed patients?
    Sommerburg O; Grune T; Hampl H; Riedel E; van Kuijk FJ; Ehrich JH; Siems WG
    Nephrol Dial Transplant; 1998 Oct; 13(10):2583-7. PubMed ID: 9794564
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of maintenance recombinant human erythropoietin therapy on ambulatory blood pressure recordings: conventional, Doppler, and tissue Doppler echocardiographic parameters.
    Kirkpantur A; Kahraman S; Yilmaz R; Arici M; Altun B; Erdem Y; Yasavul U; Turgan C
    Artif Organs; 2005 Dec; 29(12):965-72. PubMed ID: 16305652
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of Predialysis Recombinant Human Erythropoietin on Early Survival After Hemodialysis Initiation in Patients With Chronic Kidney Disease: Co-JET Study.
    Watanabe Y; Akizawa T; Saito A; Gejyo F; Suzuki M; Nishizawa Y; Tomino Y; Tsubakihara Y; Akiba T; Hirakata H; Kawanishi H; Bessho M; Udagawa Y; Aoki K; Uemura Y; Ohashi Y;
    Ther Apher Dial; 2016 Dec; 20(6):598-607. PubMed ID: 27928910
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Renal risk-benefit determinants of recombinant human erythropoietin therapy in the remnant kidney rat model - hypertension, anaemia, inflammation and drug dose.
    Ribeiro S; Garrido P; Fernandes J; Vala H; Rocha-Pereira P; Costa E; Belo L; Reis F; Santos-Silva A
    Clin Exp Pharmacol Physiol; 2016 Mar; 43(3):343-54. PubMed ID: 26889660
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of the anemia of chronic renal failure with subcutaneous recombinant human erythropoietin.
    Watson AJ; Gimenez LF; Cotton S; Walser M; Spivak JL
    Am J Med; 1990 Oct; 89(4):432-5. PubMed ID: 2220877
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Subcutaneous erythropoietin administration in predialysis patients: a single centre prospective study.
    Branger B; Vécina F; Zabadani B; Balducchi JP; Fourcade J
    Nephrol Dial Transplant; 1995; 10 Suppl 6():36-9. PubMed ID: 8524492
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiovascular effects of recombinant human erythropoietin in predialysis patients.
    Portolés J; Torralbo A; Martin P; Rodrigo J; Herrero JA; Barrientos A
    Am J Kidney Dis; 1997 Apr; 29(4):541-8. PubMed ID: 9100042
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Arterial hypertension in patients with chronic kidney insufficiency in hemodialysis with erythropoietin].
    Martins Prata M; Teixeira de Sousa F; Barbas J; Vinhaś J; Marques da Costa A
    Rev Port Cardiol; 1990 Feb; 9(2):119-23. PubMed ID: 2346662
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Erythropoietin and sexual dysfunction.
    Lawrence IG; Price DE; Howlett TA; Harris KP; Feehally J; Walls J
    Nephrol Dial Transplant; 1997 Apr; 12(4):741-7. PubMed ID: 9141005
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anemia of renal failure. Use of erythropoietin.
    Humphries JE
    Med Clin North Am; 1992 May; 76(3):711-25. PubMed ID: 1578966
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recombinant erythropoietin improves exercise capacity in anemic hemodialysis patients.
    Robertson HT; Haley NR; Guthrie M; Cardenas D; Eschbach JW; Adamson JW
    Am J Kidney Dis; 1990 Apr; 15(4):325-32. PubMed ID: 2321645
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Orally administrated Juzen-taiho-to/TJ-48 ameliorates erythropoietin (rHuEPO)-resistant anemia in patients on hemodialysis.
    Nakamoto H; Mimura T; Honda N
    Hemodial Int; 2008 Oct; 12 Suppl 2():S9-S14. PubMed ID: 18837771
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Erythropoietin associated hypertension among pediatric dialysis patients.
    Komatsu Y; Ito K
    Adv Perit Dial; 1992; 8():448-52. PubMed ID: 1361845
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Melatonin prevents oxidative stress resulting from iron and erythropoietin administration.
    Herrera J; Nava M; Romero F; Rodríguez-Iturbe B
    Am J Kidney Dis; 2001 Apr; 37(4):750-7. PubMed ID: 11273875
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Erythropoietin and cardiovascular risk.
    Allegra V; Martimbianco L; Mengozzi G; Vasile A
    Blood Purif; 1995; 13(6):301-13. PubMed ID: 8821194
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Disordered alpha 2-adrenoreceptor function in hemodialysis patients with renal anemia--a possible cause of increased blood pressure in relation to recombinant human erythropoietin?].
    Müller R; Steffen HM; Brunner R; Pollok M; Baldamus CA; Kaufmann W
    Klin Wochenschr; 1991 Oct; 69(16):742-8. PubMed ID: 1662322
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.